Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Pediatr Dermatol ; 31(5): 595-8, 2014.
Article in English | MEDLINE | ID: mdl-23458157

ABSTRACT

Kaposiform hemangioendothelioma (KHE) associated with Kasabach-Merritt phenomenon is a life-threatening vasculopathy. The current mainstay treatment for KHEs is corticosteroids and chemotherapy, but these medications do not work for all patients and carry significant side effects. We report a neonate with a large congenital KHE who responded extremely well to low-dose radiation therapy.


Subject(s)
Hemangioendothelioma/radiotherapy , Kasabach-Merritt Syndrome/radiotherapy , Sarcoma, Kaposi/radiotherapy , Diagnosis, Differential , Diagnostic Imaging , Hemangioendothelioma/congenital , Humans , Infant, Newborn , Kasabach-Merritt Syndrome/congenital , Male , Prenatal Diagnosis , Radiotherapy Dosage , Sarcoma, Kaposi/congenital
2.
Pediatr Dermatol ; 30(6): 745-7, 2013.
Article in English | MEDLINE | ID: mdl-24033678

ABSTRACT

Congenital and infantile Masson's tumors are rare. We report a case of Masson's tumors arising within a congenital vascular mass in an otherwise healthy infant. The diagnosis was made following surgical excision and supported by histologic staining. There has been no recurrence of the lesions to date.


Subject(s)
Hemangioendothelioma/pathology , Vascular Malformations/pathology , Vascular Neoplasms/pathology , Female , Hemangioendothelioma/congenital , Hemangioendothelioma/surgery , Humans , Infant, Newborn , Vascular Malformations/surgery , Vascular Neoplasms/congenital , Vascular Neoplasms/surgery
3.
Ann Dermatol Venereol ; 140(3): 209-14, 2013 Mar.
Article in French | MEDLINE | ID: mdl-23466155

ABSTRACT

BACKGROUND: Herein, we report the first case of kaposiform haemangioendothelioma (KHE) associated with acute B-lymphoblastic leukemia (B-ALL). PATIENTS AND METHODS: A five-month-old infant presented a plaque of angiomatous appearance on the forearm that had increased in volume since birth, as well as pallor and cutaneous haematomas. Kasabach-Merritt syndrome (KMS) was evoked despite hepatomegaly and considerable splenomegaly. Laboratory tests revealed severe anaemia and thrombocytopenia as well as major hyperleukocytosis with 90% blasts. Skin biopsy revealed vast vascular lobules containing cohesive fusiform endothelial cells not expressing Glut1, bound up in a dense infiltrate of B-lymphoblast cells. It was in fact KHE associated with B-ALL confirmed by the myelogram. The child was treated with the INTERFANT 2006 protocol followed by allograft of haematopoietic stem cells, which resulted in complete haematological remission. At the same time, almost total regression of KHE was noted. DISCUSSION: In this infant, KHE had an inflammatory appearance and was associated with thrombocytopenia, evocative of KMS. Analysis of blood and marrow samples resulted in a diagnosis of B-ALL. Histopathological examination of the angioma revealed a typical appearance of KHE associated with dense lymphoblastic proliferation. This appearance could have resulted either from passive contamination by circulating blast cells or from active recruitment of tumor cells at the KHE site. CONCLUSION: HK mimicking KMS may reveal B-ALL.


Subject(s)
Hemangioendothelioma/diagnosis , Kasabach-Merritt Syndrome/etiology , Leukemia, B-Cell/pathology , Neoplasms, Multiple Primary/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Skin Neoplasms/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor , Biopsy , Combined Modality Therapy , Cord Blood Stem Cell Transplantation , Cyclophosphamide/administration & dosage , Cytarabine/administration & dosage , Diagnostic Errors , Hemangioendothelioma/complications , Hemangioendothelioma/congenital , Hemangioendothelioma/pathology , Hemangioma/congenital , Hemangioma/diagnosis , Humans , Infant, Newborn , Leukemia, B-Cell/drug therapy , Leukemia, B-Cell/surgery , Male , Mercaptopurine/administration & dosage , Methotrexate/administration & dosage , Neoplasms, Multiple Primary/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/surgery , Prednisolone/administration & dosage , Remission Induction , Skin Neoplasms/complications , Skin Neoplasms/congenital , Skin Neoplasms/pathology , Transplantation, Homologous
4.
J Craniofac Surg ; 22(6): e38-41, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22134318

ABSTRACT

BACKGROUND: Kaposiform hemangioendothelioma (KHE) is a rare and aggressive vascular tumor of infancy and childhood. It is associated with the development of Kasabach-Merritt syndrome, a life-threatening consumptive thrombocytopenia. We report an interesting case of a massive periorbital congenital KHE in a neonate to raise awareness of this aggressive diagnosis. METHODS: A male neonate presented with a large congenital mass of the lower eyelid. To prevent development of amblyopia, this mass was surgically excised on the sixth day of life. RESULTS: Histologic investigation demonstrated spindle-shaped endothelial cells with surrounding crescentic vessels, which were GLUT-1 receptor-negative and D2-40 receptor-positive, consistent with KHE. Surgical excision of the periorbital KHE successfully cleared the neonate's visual axis. At 1 year of follow-up, there was no evidence of tumor recurrence, and visual development was progressing normally. A pleasing surgical result was achieved without periorbital distortion. CONCLUSIONS: Pediatric vascular tumors have historically been wrought with diagnostic confusion. With recent advances in immunohistochemistry, this previously uncharacterized group of tumors has been differentiated into multiple distinct clinical entities. Accurate and timely diagnosis is paramount because these tumors vary greatly in their clinical behavior, prognosis, and recommended treatment. Surgical excision is preferred and necessary in a neonate with visual access obstruction to prevent amblyopia and irreversible blindness.


Subject(s)
Eyelid Neoplasms/congenital , Hemangioendothelioma/congenital , Sarcoma, Kaposi/congenital , Diagnosis, Differential , Eyelid Neoplasms/pathology , Eyelid Neoplasms/surgery , Hemangioendothelioma/pathology , Hemangioendothelioma/surgery , Humans , Infant, Newborn , Male , Sarcoma, Kaposi/pathology , Sarcoma, Kaposi/surgery
5.
Pediatr Dermatol ; 26(3): 331-7, 2009.
Article in English | MEDLINE | ID: mdl-19706099

ABSTRACT

Kaposiform hemangioendothelioma is an aggressive vascular tumor, named for its striking histologic resemblance to Kaposi sarcoma and locally invasive growth. Mortality is high, and ranges from 10% to 24% for all kaposiform hemangioendothelioma lesions, with a significantly higher mortality for deep soft-tissue or visceral lesions occurring in infants less than 6 months. Mediastinal and neck kaposiform hemangioendothelioma in particular merit special discussion, as involvement of these critical anatomic locations results in significant site-specific therapeutic challenges due to invasion of vital structures, inherent delays in establishing histopathologic confirmation, and difficulties in monitoring disease status. We report our experience with three cases of mediastinal and neck kaposiform hemangioendothelioma, emphasizing the unique diagnostic and management challenges, variable response to treatment and outcome of this anatomic variant of kaposiform hemangioendothelioma.


Subject(s)
Head and Neck Neoplasms/congenital , Hemangioendothelioma/congenital , Mediastinal Neoplasms/congenital , Female , Head and Neck Neoplasms/diagnosis , Head and Neck Neoplasms/pathology , Hemangioendothelioma/diagnosis , Hemangioendothelioma/pathology , Humans , Infant , Infant, Newborn , Mediastinal Neoplasms/diagnosis , Mediastinal Neoplasms/pathology , Sarcoma, Kaposi/pathology
7.
Adv Dermatol ; 24: 105-24, 2008.
Article in English | MEDLINE | ID: mdl-19263597

ABSTRACT

Significant progress in the diagnosis of infantile vascular tumors has been achieved during the past 2 decades because of improvements in the recognition of clinical characteristics, radiologic features, and histopathologic analysis, as well as the discovery of important immunophenotypic markers such as GLUT-1. These recent advances make it possible to define more clearly the distinct clinical entities with their variable prognoses and to improve the management of lesions that, although histologically benign, infrequently may be lethal because of their invasive potential.


Subject(s)
Skin Neoplasms/congenital , Vascular Neoplasms/congenital , Diagnosis, Differential , Hemangioendothelioma/congenital , Hemangioendothelioma/diagnosis , Hemangioendothelioma/pathology , Hemangioma/congenital , Hemangioma/diagnosis , Hemangioma/pathology , Humans , Infant , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Vascular Neoplasms/diagnosis , Vascular Neoplasms/pathology
8.
J Formos Med Assoc ; 106(3 Suppl): S1-4, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17493912

ABSTRACT

Hepatic mesenchymal hamartoma is a rare benign tumor in children, and infantile hepatic hemangioendothelioma is also a rare liver neoplasm. We report a female newborn with an abdominal mass noted by the regular maternal ultrasound at 32 weeks of gestation. After birth, a liver mass was detected by computed tomography and magnetic resonance cholangiopancreatography. Frequent postprandial vomiting and progressive abdominal distension occurred 4 months later. Three tumor masses were detected this time, and the serum alpha-fetoprotein (AFP) was 6700 ng/mL. Segmental resection was performed initially and complete resection of these tumors and left lobectomy were performed 21 days later. Pathologic examination of these liver masses revealed mesenchymal hamartoma combined with infantile hepatic hemangioendothelioma. After half a year of regular follow-up, the AFP level decreased gradually to 79.5 ng/mL, without evidence of tumor recurrence.


Subject(s)
Hamartoma/congenital , Hemangioendothelioma/congenital , Liver Diseases/congenital , Liver Neoplasms/congenital , Female , Hamartoma/complications , Hamartoma/diagnosis , Hamartoma/surgery , Hemangioendothelioma/complications , Hemangioendothelioma/diagnosis , Hemangioendothelioma/surgery , Humans , Infant, Newborn , Liver Diseases/complications , Liver Diseases/diagnosis , Liver Diseases/surgery , Liver Neoplasms/complications , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Pregnancy , Prenatal Diagnosis
9.
J Am Acad Dermatol ; 54(5 Suppl): S214-7, 2006 May.
Article in English | MEDLINE | ID: mdl-16631943

ABSTRACT

Multifocal lymphangioendotheliomatosis with thrombocytopenia is an extremely rare disease. This condition manifests as diffuse congenital vascular lesions in the skin and gastrointestinal tract leading to severe gastrointestinal bleeding and thrombocytopenia. Histopathologic and immunohistochemical studies of vascular lesions demonstrate a lymphatic endothelial cell origin. Treatment often is not satisfactory. We herein describe a 4-week-old infant with this uncommon clinicopathologic entity.


Subject(s)
Gastrointestinal Tract/blood supply , Hemangioendothelioma/complications , Hemangioendothelioma/pathology , Lymphangioma/complications , Lymphangioma/pathology , Skin/blood supply , Thrombocytopenia/etiology , Adrenal Cortex Hormones/therapeutic use , Hemangioendothelioma/congenital , Hemangioendothelioma/drug therapy , Hematemesis/etiology , Humans , Immunohistochemistry/methods , Infant, Newborn , Lymphangioma/congenital , Lymphangioma/drug therapy , Male , Skin/pathology , Staining and Labeling , Vincristine/therapeutic use
10.
Pediatr Hematol Oncol ; 23(8): 639-47, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17065140

ABSTRACT

Infantile hemangioendothelioma is the most common hepatic vascular tumor in infants less than 6 months of age, with a prevalence of 1%. Serum alpha-fetoprotein levels have been used as an important tumor marker for hepatoblastoma, hepatocellular carcinoma, and germ cell tumors. It is rarely elevated in hepatic hemangioendothelioma. The authors report an infant with a hepatic hemangioendothelioma associated with elevation of serum alpha-fetoprotein who was treated with corticosteroids. In young infants, a solitary hepatic mass and elevated serum AFP level may not always be associated with hepatoblastoma. Infantile hemangioendothelioma must be differentiated by MRI or other radiological techniques before performing invasive procedures.


Subject(s)
Biomarkers, Tumor/blood , Hemangioendothelioma/blood , Liver Neoplasms/blood , Neoplasm Proteins/blood , alpha-Fetoproteins/analysis , Age Factors , Antineoplastic Agents/therapeutic use , Carcinoma, Hepatocellular/diagnosis , Diagnosis, Differential , Hemangioendothelioma/congenital , Hemangioendothelioma/diagnostic imaging , Hemangioendothelioma/drug therapy , Humans , Infant, Newborn , Liver Neoplasms/congenital , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/drug therapy , Magnetic Resonance Imaging , Male , Methylprednisolone/therapeutic use , Remission Induction , Ultrasonography
11.
An Pediatr (Barc) ; 63(1): 72-6, 2005 Jul.
Article in Spanish | MEDLINE | ID: mdl-15989875

ABSTRACT

INTRODUCTION: Kaposiform hemangioendothelioma (KHE) is a rare, frequently congenital, neoplasm associated with the Kasabach-Merritt phenomenon (KMP) and predilection for the trunk. Its clinical course is unpredictable. A child with KHE can die as a result of hemorrhage or show early spontaneous regression. In addition various and concurrent therapies can be used to treat this tumor and it is difficult to predict which treatment will be successful. MATERIAL, METHODS AND RESULTS: We present four consecutive cases of KHE (larger than 20 cm) of the thorax. All patients developed KMP, without skin involvement in one patient. Patient 1, a neonate with KHE occupying both hemithoraces (nearly 50% of the body surface area), died shortly after birth due to coagulopathy and generalized bleeding. Patient 2, a neonate, was treated with interferon alpha-2a and showed accelerated correction of coagulopathy and complete tumoral regression at 9 months. Patient 3 showed no response to steroids, interferon or vincristine therapy. Thrombocytopenia (platelet count 40,000) persisted for 8 years and was resolved by administration of aspirin plus ticlopidine, without tumoral disappearance. Patient 4 underwent incomplete removal of the tumor on her right chest wall after showing no response to antiangiogenic therapy. The coagulopathy persisted and a second radical surgical procedure resolved KMP. CONCLUSION: Given the variable response to pharmacological treatment and the scant possibilities of surgical resection, the management of KHE with KMP must include a multidisciplinary approach. As little is known about the pathogenesis of these highly aggressive vascular tumors, further molecular research is needed to understand their long-term behavior.


Subject(s)
Hemangioendothelioma , Thoracic Neoplasms , Antineoplastic Agents/therapeutic use , Fatal Outcome , Hemangioendothelioma/congenital , Hemangioendothelioma/drug therapy , Hemangioendothelioma/physiopathology , Hemangioendothelioma/surgery , Humans , Infant , Infant, Newborn , Interferon alpha-2 , Interferon-alpha/therapeutic use , Recombinant Proteins , Sarcoma, Kaposi , Syndrome , Thoracic Neoplasms/congenital , Thoracic Neoplasms/drug therapy , Thoracic Neoplasms/physiopathology , Thoracic Neoplasms/surgery , Thrombocytopenia/etiology
12.
Am J Surg Pathol ; 21(10): 1231-5, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9331297

ABSTRACT

Vascular tumors of the female genital tract are uncommon, and only a few cases have been reported in the ovary. We describe herein, an unusual tumor of the ovary: infantile hemangioendothelioma (cellular hemangioma of infancy) in a newborn. The tumor consisted of well-formed blood vessels and proliferating endothelial cells that were arranged in solid cordlike structures. The tumor permeated the ovarian stroma and entrapped normal ovarian follicles. By immunohistochemistry the neoplastic cells expressed factor VIII, CD34, and alpha smooth-muscle actin, and ultrastructurally they had the features of endothelial cells that were focally associated with pericytes. We examined simple sequence repeat (SSR) polymorphic markers in the tumor tissue, as well as in the patient's and parents' blood. The informative SSR markers were found to be identical in the tumor and in the patient's somatic cells. We suggest that the tumor described herein is a congenital infantile hemangioendothelioma arising from ovarian parenchymal cells rather than a teratoma originating from germ cells. A similar morphologic lesion has been described recently in the ovary and interpreted as monodermal teratoma composed of vascular tissue.


Subject(s)
Hemangioendothelioma/pathology , Ovarian Neoplasms/pathology , Actins/analysis , Antigens, CD34/analysis , Diagnosis, Differential , Female , Hemangioendothelioma/chemistry , Hemangioendothelioma/congenital , Hemangioendothelioma/genetics , Humans , Immunohistochemistry , Infant, Newborn , Microscopy, Electron , Ovarian Neoplasms/chemistry , Ovarian Neoplasms/genetics , Polymorphism, Genetic , Teratoma/chemistry , Teratoma/genetics , Teratoma/pathology , von Willebrand Factor/analysis
13.
Pediatrics ; 79(6): 960-6, 1987 Jun.
Article in English | MEDLINE | ID: mdl-3588149

ABSTRACT

The case report of a newborn infant with a splenic hemangioendothelioma with the life-threatening complications of thrombocytopenia, anemia, and disseminated intravascular coagulation is presented together with a review of the literature. Removal of the tumor via splenectomy, despite the known risk of subsequent overwhelming sepsis due to encapsulated organisms in the young child, is the treatment of choice for splenic hemangiomas complicated by thrombocytopenia. The use of enhanced CT with delayed filling is a diagnostic tool in the workup of suspected hemangiomatous lesions.


Subject(s)
Disseminated Intravascular Coagulation/etiology , Hemangioendothelioma/congenital , Splenic Neoplasms/congenital , Thrombocytopenia/etiology , Anemia, Neonatal/etiology , Female , Humans , Infant, Newborn
14.
Ann Thorac Surg ; 74(3): 914-6, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12238864

ABSTRACT

Primary intracardiac neoplasms are most commonly histologically benign with only 30% exhibiting signs of malignancy. Metastatic tumors of the heart are 30 times more common than primary cardiac tumors. Patients with intracardiac masses may present with dyspnea on exertion, thromboembolic events, pericarditis, arrhythmias, or congestive heart failure. In many, however, the diagnosis is made upon discovering a murmur in an otherwise asymptomatic patient. Hemangioendotheliomas are very rare tumors of the heart characterized by capillary-sized vessels lined by rounded and often multilayered endothelial cells. Cardiac muscle cells are found compressed between proliferating vascular channels. We present a patient with this unusual cardiac tumor with no previous cardiac history and a new systolic murmur.


Subject(s)
Heart Neoplasms/surgery , Heart Ventricles/surgery , Hemangioendothelioma/surgery , Endothelium, Vascular/pathology , Female , Heart Neoplasms/congenital , Heart Neoplasms/pathology , Heart Ventricles/pathology , Hemangioendothelioma/congenital , Hemangioendothelioma/pathology , Humans , Infant
15.
Ann Thorac Surg ; 59(6): 1575-7, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7771849

ABSTRACT

We report on the management of a neonate undergoing arterial switch for transposition of the great arteries and concomitant resection of a hepatic infantile hemangioendothelioma. A preoperative aortogram demonstrated the arterial supply of the hepatic hemangioendothelioma. Pulmonary artery hypertension and myocardial ischemia were noted after separation from cardiopulmonary bypass. Resection of the hepatic malformation produced an immediate reduction in pulmonary hypertension and resolution of the myocardial ischemia. The patient had an uneventful postoperative recovery.


Subject(s)
Hemangioendothelioma/surgery , Liver Neoplasms/surgery , Transposition of Great Vessels/surgery , Female , Hemangioendothelioma/complications , Hemangioendothelioma/congenital , Hemangioendothelioma/diagnosis , Humans , Hypertension, Pulmonary/etiology , Infant, Newborn , Liver Neoplasms/complications , Liver Neoplasms/congenital , Liver Neoplasms/diagnosis , Myocardial Ischemia/etiology , Transposition of Great Vessels/complications
16.
Arch Dermatol ; 136(7): 905-14, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10890993

ABSTRACT

OBJECTIVES: To discuss the current knowledge regarding complicated hemangiomas (cervicofacial, periorbital, lumbosacral, and parotid), including the associated syndromes of diffuse neonatal hemangiomatosis and PHACES (posterior fossa malformations, most commonly of the Dandy-Walker variant; hemangiomas [especially large, plaquelike, facial lesions]; arterial anomalies; cardiac anomalies and coarctation of the aorta; eye abnormalities; and sternal cleft and/or supraumbilical raphe). To discuss 2 newly recognized entities that may be a source of diagnostic confusion with the common hemangioma, the kaposiform hemangioendothelioma and tufted angioma. To discuss the risks and benefits of current treatment options, including the use of systemic corticosteroids and interferon in necessary situations. DATA SOURCES: The pertinent world literature was reviewed and incorporated into experience from our pediatric dermatology practice at the University of Texas Medical School at Houston. CONCLUSIONS: The common hemangioma, kaposiform hemangioendothelioma, and tufted angioma, though benign histologically, may cause serious consequences for children. Dermatologists should be able to recognize unique clinical presentations of these lesions and obtain further diagnostic evaluation accordingly. Dermatologists should also be aware of available treatment options, including the use of systemic chemotherapy in life-threatening situations.


Subject(s)
Hemangioma , Skin Neoplasms , Abnormalities, Multiple , Hemangioendothelioma/congenital , Hemangioendothelioma/diagnosis , Hemangioendothelioma/pathology , Hemangioendothelioma/therapy , Hemangioma/congenital , Hemangioma/diagnosis , Hemangioma/pathology , Hemangioma/therapy , Humans , Infant , Infant, Newborn , Skin Neoplasms/congenital , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Skin Neoplasms/therapy , Syndrome
17.
Radiographics ; 24(3): 755-72, 2004.
Article in English | MEDLINE | ID: mdl-15143226

ABSTRACT

Abnormal vascular connections within the hepatic parenchyma are occasionally seen at ultrasonography (US) and require further evaluation. The radiologic findings in 42 children with infantile hepatic hemangioma (n = 28), vascular malformations (n = 10), or infradiaphragmatic total anomalous pulmonary venous return (TAPVR) (n = 4) associated with congenital vascular shunting were retrospectively reviewed. Arteriovenous connections are seen in infantile hepatic hemangiomas and arteriovenous malformations and manifest with aortic tapering at the level of the celiac trunk, hepatic artery enlargement with a low resistivity index (RI), and increased flow velocities in the hepatic veins that may assume an arterialized spectral pattern in late-stage disease. Congenital arterioportal shunts demonstrate a low RI in the hepatic artery, hepatofugal arterialized flow in the portal vein, and rapid development of signs of portal hypertension. Portosystemic shunting may be intra- or extrahepatic. A pulsatile triphasic spectral pattern is seen in the portomesenteric venous system in children with portosystemic shunting, and macroscopic connections between the portal system and the hepatic veins are evident. Infradiaphragmatic TAPVR is associated with a tortuous vessel that parallels the aorta, ends at the intrahepatic left portal vein or the ductus venosus, and has hepatopetal flow. Familiarity with the US features of various congenital abnormal hepatic vascular connections will aid in diagnosis and treatment.


Subject(s)
Arteriovenous Malformations/diagnostic imaging , Hemangioma/congenital , Liver Neoplasms/congenital , Liver/blood supply , Pulmonary Veins/abnormalities , Abnormalities, Multiple/diagnostic imaging , Adolescent , Arteriovenous Fistula/congenital , Arteriovenous Fistula/diagnostic imaging , Arteriovenous Fistula/embryology , Arteriovenous Malformations/embryology , Arteriovenous Malformations/surgery , Heart Defects, Congenital/diagnostic imaging , Hemangioendothelioma/congenital , Hemangioendothelioma/diagnostic imaging , Hemangioma/diagnostic imaging , Hepatic Artery/abnormalities , Hepatic Artery/diagnostic imaging , Hepatic Artery/embryology , Hepatic Veins/abnormalities , Hepatic Veins/diagnostic imaging , Hepatic Veins/embryology , Humans , Infant , Infant, Newborn , Liver/diagnostic imaging , Liver/embryology , Liver Neoplasms/diagnostic imaging , Portal Vein/abnormalities , Portal Vein/diagnostic imaging , Portal Vein/embryology , Portography , Prognosis , Pulmonary Veins/diagnostic imaging , Retrospective Studies , Tomography, X-Ray Computed , Ultrasonography
18.
J Pediatr Surg ; 27(10): 1291-3, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1403505

ABSTRACT

Two 3-month-old girls presented with posterior mediastinal juvenile hemangioma (JH), a benign tumor rarely found in the mediastinum. Incomplete resections were performed. Over 4 and 7 months, respectively, the hemangiomas recurred and grew through the tracheal wall into the tracheal lumina, reducing the airway by 90% in one case and 70% in the other. The recurrences were resected, including five tracheal rings in the first case and four in the second. In case 1 the tumor recurred in the trachea 2 months later. A tracheostomy was performed, and corticosteroids were administered for 6 months. The tumor involuted and the patient was decannulated after 18 months; she is doing well 7 years later. The patient in case 2 has been well in the 18 months since her second operation. Airway obstructions can be treated by tracheal resection when conservative management fails.


Subject(s)
Hemangioendothelioma/congenital , Tracheal Neoplasms/congenital , Airway Obstruction/pathology , Airway Obstruction/surgery , Bronchoscopy , Combined Modality Therapy , Female , Hemangioendothelioma/pathology , Hemangioendothelioma/surgery , Humans , Infant , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Prednisone/administration & dosage , Trachea/pathology , Tracheal Neoplasms/pathology , Tracheal Neoplasms/surgery , Tracheostomy
20.
Eur J Pediatr Surg ; 12(5): 348-52, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12469266

ABSTRACT

A small number of cavernous liver hemangiomas in infants cause serious symptoms, requiring active treatment. We report two newborns with giant liver hemangiomas, treated by intra-arterial embolization. The babies presented at 2 - 8 days after birth with tachypnoea and cardiac dilation. A giant liver hemangioma located in the right liver lobe in one infant and in the left liver lobe in the other was found at ultrasonography and computed tomography. Dilated liver veins indicated abnormal shunting of the blood through the hemangiomas. Because of progress of symptoms superselective embolization of the arteries feeding the hemangiomas and arising from the celiac trunk was performed with a mixture of Lipoidol and Histoacryl. A decrease of tachypnoea and of heart volume was noted after embolization. In one infant surgery was necessary due to gastrointestinal bleeding. The intra-arterial embolization is a valuable method for the treatment of newborns with symptomatic cavernous liver hemangiomas.


Subject(s)
Embolization, Therapeutic , Hemangioendothelioma/congenital , Hemangioendothelioma/therapy , Hemangioma, Cavernous/congenital , Hemangioma, Cavernous/therapy , Liver Neoplasms/congenital , Liver Neoplasms/therapy , Diseases in Twins , Gastrointestinal Hemorrhage/etiology , Hemangioendothelioma/complications , Hemangioendothelioma/pathology , Hemangioma, Cavernous/complications , Hemangioma, Cavernous/pathology , Humans , Infant, Newborn , Liver Neoplasms/complications , Liver Neoplasms/pathology , Male , Respiration Disorders/etiology
SELECTION OF CITATIONS
SEARCH DETAIL